On March 12, 2026, Andreas Busch, the Chief Innovation Officer at $ABSI, bought 100,000 shares of his company’s stock for about $229,000. This information comes from Quiver Quantitative and is based on recent SEC filings. With this purchase, their ownership in this class of shares has increased by roughly 31.1%. Now, they hold a total of 421,446 shares of $ABSI.
$ABSI Insider Trading Activity
In the past six months, insiders at $ABSI have engaged in stock trading six times in the open market. Out of these trades, insiders bought four times and sold two times.
Here’s a summary of the latest insider transactions for $ABSI over the last six months:
- MENELAS N PANGALOS purchased 95,785 shares for around $254,788.
- Andreas Busch bought 100,000 shares for about $229,000.
- Houtenflanvin acquired 40,000 shares at an estimated cost of $148,800.
- Sean McClain, the CEO, sold 26,761 shares for roughly $80,015.
- Zachariah Jonathon, CFO/CBO, sold 17,496 shares for about $52,313.
- TODD BEDRICK, SVP, CAO, purchased 10,000 shares for an estimated $27,000.
$ABSI Hedge Fund Activities
In recent months, 67 institutional investors added shares of $ABSI to their portfolios, while 70 reduced their positions in the most recent quarter.
Here are some significant recent transactions:
- STATE Street CORP increased its holdings by 3,925,926 shares (+190.1%) in Q4 2025, totaling $13,701,481.
- SCHONFELD STRATEGIC ADVISORS LLC added 2,349,725 shares in Q4 2025, valued at $8,200,540.
- Baker Brothers ADVISORS LP acquired an additional 2,134,803 shares in Q4 2025, totaling $7,450,462.
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,085,501 shares in Q4 2025, amounting to $7,278,398.
- CITADEL ADVISORS LLC increased its stake by 1,778,545 shares in Q4 2025, with a value of $6,207,122.
- PARKMAN HEALTHCARE PARTNERS LLC added 1,458,652 shares in Q4 2025, worth $5,090,695.
- TWO SIGMA INVESTMENTS, LP bought 1,291,261 shares in Q4 2025, totaling $4,506,500.
$ABSI Analyst Rating
In recent months, Wall Street analysts have issued reports on $ABSI, with three firms recommending a buy and none issuing a sell rating.
Recent analyst assessments include:
- HC Wainwright & Co. gave a “buy” rating on December 18, 2025.
- Needham also issued a “buy” rating on November 13, 2025.
- JP Morgan rated the stock as “overweight” on February 10, 2025.
$ABSI Target Price
Several analysts have set price targets for $ABSI. Two analysts have released targets over the last six months, with a median target of $7.5.
Recent target prices include:
- Swayampakula Ramakanth from Wainwright & Company has a target of $8.0 as of December 18, 2025.
- Gil Blum from Needham has set a target of $7.0 as of December 12, 2025.
This article is not financial advice. For more details, please refer to the Quiver Quantitative Disclaimer.
